Drug Profile
Gefitinib companion diagnostic - AstraZeneca/QIAGEN
Alternative Names: Circulating tumour DNA test - AstraZeneca/QIAGEN; Liquid biopsy based gefitinib companion diagnostic - AstraZeneca/QIAGEN; therascreen EGFR RGQ PCR Kit (gefitinib)Latest Information Update: 15 Jul 2015
Price :
$50
*
At a glance
- Originator QIAGEN
- Developer AstraZeneca; QIAGEN
- Class Diagnostic agents
- Mechanism of Action
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Non-small cell lung cancer